FDA detains imports of Mexican cucumbers
The Food and Drug Administration is detaining imports of cucumbers from a Mexican company because they were linked to salmonella illnesses in 18 states. The FDA placed the restrictions against Daniel Cardenas Izabal and Miracle Greenhouse of Culiacán, Mexico. The alert means the United States won't accept the imports unless the company can show testing that proves the cucumbers are safe.
The federal Centers for Disease Control and Prevention said Thursday that 73 people may have been sickened by the cucumbers.
Salmonella can cause diarrhea, abdominal cramps and fever within a few days of eating a contaminated product. Salmonella can be life-threatening to those with weakened immune systems.
The cucumbers were distributed by Tricar Sales, Inc. of Rio Rico, Arizona. California reported the most illnesses, with 28 people sickened.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Wolf reverses Corbett, says deal between Highmark, UPMC doesn’t limit continuity of care to very ill
- Researchers: U.S. lacks proving ground for nuclear energy innovations
- Mud serves as multipurpose tool in $100B shale industry
- IPO might test Etsy’s approach to commerce
- Big banks’ levels of capital strong, Federal Reserve finds
- Race toward bigger phones eases
- Americans see improved job market but a vulnerable economy, Pew poll finds
- AbbVie to buy leukemia drugmaker Pharmacyclics for $21 billion
- Stocks snap losing streak as ECB reveals stimulus start date
- Cleveland district, including Pittsburgh, shows moderate economic growth in latest Beige Book report from Fed
- Toyota Mirai to run on hydrogen fuel cells, widen green-vehicle divide